Cuffless Blood Pressure Monitoring Devices: Technical Foundations and Clinical Implications Scientific Statement of the European Society of Cardiology (ESC) Working Group on e-Cardiology, the ESC Council on Hypertension, and the European Association of Preventive Cardiology of the ESC
European Journal of Preventive Cardiology

Abstract
Cuffless blood pressure (BP) monitoring devices represent a promising innovation in hypertension management. This scientific statement provides a comprehensive update on these emerging technologies, their specific validation requirements, their potential clinical applications, and their present and future challenges.
These devices generate considerable interest by enabling non-invasive BP measurement without arterial occlusion, thereby eliminating the discomfort associated with traditional cuff-based monitoring, particularly during sleep. The technologies on which these devices are based comprise a heterogeneous group, primarily utilizing pulse wave propagation time or waveform analysis through contact or non-contact sensors. They can be categorized as continuous or intermittent, automated or manual, calibration-free or requiring cuff/demographic calibration, and wearable or stationary. This technological diversity necessitates validation protocols distinct from those used for conventional cuff-based monitors, with specific requirements for each device category.
Potential clinical applications include widespread out-of-office BP monitoring, unbiased assessment of circadian BP patterns and BP variability, improved detection of nocturnal hypertension, enhanced treatment adherence and long-term BP control, and continuous monitoring in hospital settings. Additionally, their lower cost compared with conventional technologies could enhance the early detection of hypertension in resource-limited settings. However, due to insufficient accuracy validation, this scientific statement does not recommend their use in clinical decisions in spite of their potential interest, in line with international guidelines not recommending their use in hypertension management. Key challenges ahead include developing standardized validation protocols, establishing normative BP data, managing the resulting burden on clinicians in handling huge volumes of data, exploring additional haemodynamic parameters, and advancing sensor technology, mathematical models, and algorithms.
Contributors

Juan Eugenio Ochoa
Author

Ana Abreu
Author

Rosa Maria Bruno
Author

Enrico G Caiani
Author

Ruben Casado-Arroyo
Author

Matthijs Cluitmans
Author

Constantinos H Davos
Author

Polychronis Dilaveris
Author

Federico Guerra
Author

Henner Hanssen
Author

Magnus T Jensen
Author

Thomas Kahan
Author

Harold Kemps
Author

Paul Leeson
Author

Emanuela T Locati
Author

Joost Lumens
Author

Felix Mahfoud
Author

José Millet Roig
Author

Theodoros G Papaioannou
Author

Pyotr G Platonov
Author

Julia Ramirez
Author

Mark J Schuuring
Author

Roderick Willem Treskes
Author

Alberto Avolio
Author

Paolo Castiglioni
Author
You may be interested in






